Sekkei Bio Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74999TN2017PTC130748 Incorporated 28 November 2017 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma DPIIT Startup MSME · Micro
Revenue · FY 2024
₹2.13 Cr
▲ 4734% YoY
Net loss · FY 2024
₹2.95 Cr
Net margin -138.6%
EBITDA · FY 2024
-₹2.91 Cr
EBITDA margin -136.8%
Authorised capital
₹21.5 Lakh
Registered with MCA
Paid-up capital
₹2.46 Lakh
Issued & subscribed
Open charges
₹3.25 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
23
Provident fund records

About Sekkei Bio Private Limited

Data last updated:

Sekkei Bio Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 November 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2017PTC130748. Its GSTIN is 33AAZCS5187Q1Z3 (Tamil Nadu). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹21.5 Lakh and a paid-up capital of ₹2.46 Lakh. It is led by directors including Anand Prakash Khedkar and Gauri Anand Khedkar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Iitm Bioincubator Iit Madras Research Park 3rd Floor Kanagam Road Taramani, Chennai, Tamil Nadu, India – 600113.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.13 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.95 Cr (net margin -138.6%) and EBITDA of -₹2.91 Cr (EBITDA margin -136.8%). Revenue has grown at a compounded annual rate (CAGR) of 78% over five years.

The company has about 23 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Sekkei Bio. As per MCA filings, the company has open charges of ₹3.25 Cr on record. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹4.36 Cr; the latest was in June 2021. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Sequence Biotech Private Limited with revenue of ₹2.19 Cr.

Sekkei Bio Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0080616). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sekkeibio.com.

Company details

CIN U74999TN2017PTC130748
Registration Number 130748
Incorporation Date 28 November 2017
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0080616

CIN history

Sekkei Bio has one previous CIN (Corporate Identification Number): U74999KA2017PTC108263. The current CIN is U74999TN2017PTC130748, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74999TN2017PTC130748Current
U74999KA2017PTC108263Previous

Recognitions & Rankings of Sekkei Bio

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-TN-02-0080616

Contact details

Sekkei Bio Private Limited's registered office is in Chennai, Tamil Nadu. Its website is sekkeibio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Iitm Bioincubator Iit Madras Research Park 3rd Floor Kanagam Road Taramani, Chennai, Tamil Nadu, India – 600113
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sekkei Bio Private Limited, buy the company report.

Comprehensive company report
Sekkei Bio Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sekkei Bio operates one associated brand: Sekkei Bio. Each brand links to its own profile.

BrandDescriptionWebsite
Drugs and vaccines for multiple diseases are developed.sekkeibio.com

Business activity

The main business activity of Sekkei Bio is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sekkei Bio Private Limited, buy the company report.

Financials of Sekkei Bio Private Limited

FY 2025 filings available

Sekkei Bio Private Limited reported revenue of ₹2.13 Cr (up 4734% YoY) for FY 2024.

Revenue · FY 2024
₹2.13 Cr ▲ 4734%
Net loss · FY 2024
₹2.95 Cr margin -138.6%
EBITDA · FY 2024
-₹2.91 Cr margin -136.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
5 years · compounded
▲ 78%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 94%
5 years · compounded
▼ 82%

Revenue has grown at a compounded annual rate (CAGR) of 78% over five years. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.91 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.95 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-136.8%
Net Profit Margin-138.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sekkei Bio Private Limited, buy the company report.

Board of directors of Sekkei Bio Private Limited

Sekkei Bio has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anand Prakash KhedkarDirector28 Nov 20178 Years 11 MonthsCurrent
Gauri Anand KhedkarDirector23 Mar 20197 Years 7 MonthsCurrent
Monalisa ChatterjiDirector28 Nov 20178 Years 11 MonthsCurrent
Ranganathan AnirudhDirector11 Jun 20215 Years 5 MonthsCurrent

Peer comparison

Sekkei Bio Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sequence Biotech Private Limited₹2.19 Cr (FY 2025)-27.0%Nashik, Maharashtra, India
Sekkei Bio Private Limitedthis company₹2.13 Cr (FY 2024)-₹2.95 Cr-138.6%4734.0%23Chennai, Tamil Nadu, India
Vasanthu Biotech Private Limited₹2.12 Cr (FY 2025)-35.0%Hyderabad, Telangana, India
Relic Biotechnology Private Limited₹2.09 Cr (FY 2025)-8.0%Pune, Maharashtra, India

To see the full peer comparison of Sekkei Bio Private Limited, buy the company report.

Auditor

Sekkei Bio Private Limited is audited by MOHAN SRIDHAR & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
MOHAN SRIDHAR & COFY 2020013857S

Shareholding

The shareholding of Sekkei Bio Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Sekkei Bio Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹3.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Mar 2025101096819Others₹3.25 CrOpen

Total charge records: 1 View all charges

Deals & funding

Sekkei Bio Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹4.36 Cr; the latest was in June 2021.

Total deals
2
Funding rounds
2
Disclosed funding
₹4.36 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Jun 2021Funding round · Series A₹4.11 CrInvestors: Tenshi Life Sciences Private Limited , 3 individuals
Feb 2021Funding round · Seed₹25 LakhInvestors: Tenshi Life Sciences Private Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sekkei Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sekkei Bio Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
23
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2723
FY 2025-26

To see the full employee and EPFO history of Sekkei Bio Private Limited, buy the company report.

GST

Sekkei Bio has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AAZCS5187Q1Z3Tamil NaduActive23 Sep 2019
29AAZCS5187Q1ZSKarnatakaActive22 Dec 2017

To see the full GST registrations and return filing status of Sekkei Bio Private Limited, buy the company report.

Recent activity

Sekkei Bio Private Limited has 6 board changes on record since 2017: 4 appointments and 2 cessations. The latest: Ranganathan Anirudh ceased to be Additional Director on 30 Nov 2021.

AGM
Sekkei Bio Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sekkei Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others amounted to Rs. 325.00 Lakh with Charge ID 101096819 was registered on 31 Mar 2025.
Ceased
Ranganathan Anirudh ceased to be Additional Director.
Appointed
Ranganathan Anirudh was appointed as Director.
Ceased
Gauri Anand Khedkar ceased to be Additional Director.
Appointed
Gauri Anand Khedkar was appointed as Director.
Appointed
Anand Prakash Khedkar was appointed as Director.
Appointed
Monalisa Chatterji was appointed as Director.
Incorporation
28 Nov 2017
Sekkei Bio Private Limited was registered on 28 Nov 2017 with Roc Chennai & aged 8 years 11 months as per MCA records.

Frequently asked questions

Sekkei Bio is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 November 2017 (9+ years old) and is registered under CIN U74999TN2017PTC130748.

Sekkei Bio has 4 current directors:

The latest financial statements of Sekkei Bio on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Sekkei Bio is 33AAZCS5187Q1Z3, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAZCS5187Q1ZS (Karnataka).

The CIN (Corporate Identification Number) of Sekkei Bio is U74999TN2017PTC130748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sekkei Bio was incorporated on 28 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.

Sekkei Bio has 2 deals on record (2 funding rounds), with disclosed funding of ₹4.36 Cr; the latest was in June 2021.

The peers of Sekkei Bio by revenue are Sequence Biotech Private Limited, Vasanthu Biotech Private Limited, Relic Biotechnology Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ranganathan Anirudh ceased to be Additional Director on 30 Nov 2021. Ranganathan Anirudh was appointed as Director on 11 Jun 2021. Gauri Anand Khedkar ceased to be Additional Director on 30 Sep 2019. Sekkei Bio has 6 board changes on record in total.

Yes, Sekkei Bio is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Sekkei Bio is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0080616).